CA
NZ
UK
AU
IND
US
Ondas Holdings Inc. (NASDAQ: ONDS) delivered a strong third quarter performance for 2025, reflecting rapid growth in defense technology and autonomous systems markets. The company reported revenue of USD 10.1 million, representing a remarkable 580% increase from the same period last year.
Praxis Precision Medicines reported fourth quarter and full-year 2025 financial results alongside major pipeline updates as the biotechnology company moves closer to potential commercialization.
SanDisk Corporation reported strong financial performance in fiscal Q2 2026, as pricing recovery across the NAND market and rising demand from artificial intelligence infrastructure supported growth across its end markets.
The intersection of capital markets and digital assets has increasingly become a defining feature of modern corporate treasury strategies. Over the past several years, a small group of companies have adopted unconventional approaches to balance sheet management by allocating capital to cryptocurrencies.
Platinum futures climbed above USD 2,200 an ounce this week, rebounding from a two-week low as a softening U.S. dollar lifted demand for precious metals. After peaking above USD 2,700 in January 2026 and sliding to USD 2,000 in February, platinum futures have rebounded …
Market Movers:On Monday, the top gainers were Garden Stage Limited (+151.54%), followed by AN2 Therapeutics, Inc. (+84.21%). On the contrary, Innovation Beverage Group Limited. (-40.14%), and TMD Energy Limited (-26.37%) declined the most the same day.
Key Drivers Heading into Today’s Session
IREN Limited reported its financial results for the second quarter of fiscal year 2026, highlighting a continued strategic transition from Bitcoin mining toward AI cloud infrastructure. The shift reflects a structural opportunity emerging from accelerating demand for high performance computing capacity driven by artificial …
Hecla Mining Company reported record financial and operational results for the fourth quarter and full year, supported by strong silver prices and improved operational productivity across its core mines.
Lexicon Pharmaceuticals reported stronger than expected financial results for the fourth quarter of 2025, delivering an earnings surprise and higher than projected revenue. The company posted earnings per share of USD -0.04, outperforming analyst estimates of USD -0.07.
Please wait processing your request...